Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Sees Significant Growth in Short Interest

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) was the target of a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 3,100 shares, an increase of 6.9% from the January 15th total of 2,900 shares. Based on an average daily volume of 11,900 shares, the short-interest ratio is currently 0.3 days.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in IBBQ. Tower Research Capital LLC TRC raised its holdings in shares of Invesco Nasdaq Biotechnology ETF by 148.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 28,061 shares of the company’s stock worth $604,000 after purchasing an additional 16,768 shares during the period. Raymond James Financial Inc. bought a new stake in shares of Invesco Nasdaq Biotechnology ETF in the fourth quarter valued at $888,000. Advisory Services Network LLC lifted its position in shares of Invesco Nasdaq Biotechnology ETF by 5.8% during the 4th quarter. Advisory Services Network LLC now owns 53,609 shares of the company’s stock valued at $1,154,000 after buying an additional 2,922 shares during the last quarter. Strategic Financial Concepts LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF during the 4th quarter worth $1,699,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its holdings in Invesco Nasdaq Biotechnology ETF by 22.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after acquiring an additional 48,137 shares during the last quarter.

Invesco Nasdaq Biotechnology ETF Price Performance

Shares of Invesco Nasdaq Biotechnology ETF stock opened at $22.58 on Tuesday. The stock has a fifty day moving average price of $22.09 and a 200-day moving average price of $23.11. The firm has a market cap of $39.97 million, a PE ratio of 17.39 and a beta of 0.61. Invesco Nasdaq Biotechnology ETF has a 1 year low of $20.14 and a 1 year high of $24.84.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 27th. Shareholders of record on Monday, December 23rd were given a $0.0619 dividend. The ex-dividend date of this dividend was Monday, December 23rd.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.